Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-052088
Filing Date
2025-04-08
Accepted
2025-04-08 16:25:04
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-08

Document Format Files

Seq Description Document Type Size
1 ARS rgnx-ars-2024.pdf ARS 1313191
  Complete submission text file 0000950170-25-052088.txt   1809928
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37553 | Film No.: 25822293
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)